Trials / Completed
CompletedNCT07473557
Clinical Outcomes of the Use of a Femtosecond Laser on an Implanted Intraocular Lens
A Prospective Study to Assess the Clinical and Refractive Outcomes of the Use of a Femtosecond Laser on an Implanted Intraocular Lens
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Perfect Lens, LLC · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is a prospective non-randomized patient controlled single center study which is designed to evaluate the clinical outcomes of the treatment of an implanted intraocular lens using a low-energy femtosecond laser for refractive correction.
Detailed description
The purpose of this research study is to evaluate the safety and efficacy of the treatment of an implanted intraocular lens with a device. The device employs a generic femtosecond laser used in numerous other ophthalmic procedures. The device uses low levels of energy from the femtosecond laser to correct spherical, cylindrical and sphero-cylindrical refractive error existing in an implanted intraocular lens. The refractive correction is effected through the treatment, which is employed at least 30 days after cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Device | The Perfector is used in the procedure. The device is attached to the patient by the use of a patient attachment. The patient attachment attaches to the sclera of the eye using vacuum pressure. |
Timeline
- Start date
- 2019-01-18
- Primary completion
- 2022-09-16
- Completion
- 2022-09-16
- First posted
- 2026-03-16
- Last updated
- 2026-03-19
Locations
1 site across 1 country: Panama
Source: ClinicalTrials.gov record NCT07473557. Inclusion in this directory is not an endorsement.